Researchers at NASA’s Langley Research Center in Hampton, Virginia, are testing drones as a potentially more efficient way to deliver donated kidneys. Their June 5 trials demonstrated how drone flights could streamline the transportation of these vital organs.
A biotech startup focused on eye diseases has secured $330 million in funding, gearing up for late-stage testing of its treatments. This significant investment marks a pivotal moment in ophthalmology care and underlines the growing interest in targeted therapies for chronic conditions.
Omnix Medical has begun enrolling patients in a Phase II trial of OMN6, a new antimicrobial compound designed to physically disrupt pathogenic bacteria. This breakthrough approach underscores the potential for a novel treatment pathway that could reshape the landscape of antibacterial therapies.
A cutting-edge air medic program is bringing portable heart pumps by helicopter to the outskirts of the Twin Cities. In a historic first for the United States, a cardiac arrest victim in Belle Plaine received life-saving care in the back of an ambulance.
A new generation of medications first developed for diabetes is now offering hope for chronic kidney disease patients. Three types of these drugs, including one famously known as Ozempic, are transforming the outlook for individuals who have long waited for more effective treatment options.
In 1900, Viennese instrument maker Erwin Perzy was asked to create a brighter light for a hospital’s operating room. The request aligned with a broader tech wave spurred by Thomas Edison’s 1879 patent, sparking innovative solutions in medical illumination.
Scientists have taken a curious concept once linked to an Ig Nobel prize and validated it in a human safety trial. Known as “butt-breathing” and formally called enteral ventilation, this technique might soon offer a new way to deliver oxygen.
Robert H. Bartlett, M.D., renowned as the Father of ECMO, has died at the age of 86 after a long illness. Bartlett was an active emeritus surgeon at Michigan Medicine and served as a professor at the University of Michigan Medical School.
Researchers at UTHealth Houston have made a significant leap toward decoding speech directly from the human brain. Their work, published in Nature Communications, points to a future where understanding silent thoughts and turning them into spoken words could become a reality.
With limited treatment options for stroke patients, two UConn researchers are developing a drug that aims to protect the brain and speed recovery. Strokes, or cerebral vascular accidents, can be life-altering, and this experimental therapy may offer a valuable new approach in addressing their debilitating impact.
